Health Care M&A Faces Antitrust Enforcement Crackdown
By Kaj Rozga (August 23, 2021, 6:19 PM EDT) -- Antitrust scrutiny of large technology companies may be in the headlines, but what some have dubbed BigMed is being eyed by the Biden administration and federal agencies for heightened antitrust enforcement.
Hospitals, physician groups and health plans already accustomed to an active antitrust enforcement climate may need to prepare for even choppier regulatory waters ahead as a new president and new leadership at the Federal Trade Commission and U.S. Department of Justice turn their focus on provider markets for health care.
Here, we look at the latest developments in competition policy and enforcement in provider markets, before turning to their impact...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!